MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1078.14%
Quick Ratio
1078.14%
Cash Ratio
409.41%
Debt to Asset Ratio
14.20%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock-Series XRedeemab...
    • Others
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
96,280
76,319
Short-term investments
131,441
182,859
Accounts receivable
17,243
-
Prepaid expenses and other current assets
8,582
9,408
Total current assets
253,546
268,586
Right-of-use asset
4,254
4,546
Other assets
14,066
8,792
Total assets
271,866
281,924
Accounts payable
1,137
738
Accrued expenses
16,481
15,907
Operating lease liabilities, current
1,404
1,399
Deferred revenue, current
4,495
-
Total current liabilities
23,517
18,044
Operating lease liabilities, net of current portion
3,055
3,367
Deferred revenue, net of current portion
12,041
-
Preferred stock-Nonredeemable Preferred Stock
-
0
Total liabilities
38,613
21,411
Preferred stock-Series XRedeemable Convertible Preferred Stock
95,324
95,324
Common stock, 0.001 par value per share, 150,000,000 shares authorized 56,434,894 and 56,434,219 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
57
57
Additional paid-in capital
911,014
906,703
Accumulated other comprehensive gain
56
-16
Accumulated deficit
-773,198
-741,555
Total stockholders' equity
233,253
260,513
Total liabilities and stockholders' equity
271,866
281,924
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$131,441K Cash and cashequivalents$96,280K Accounts receivable$17,243K Prepaid expenses andother current assets$8,582K Total current assets$253,546K Other assets$14,066K Right-of-use asset$4,254K Total assets$271,866K Total liabilities andstockholders' equity$271,866K Total stockholders'equity$233,253K Total liabilities$38,613K Accumulated deficit-$773,198K Additional paid-in capital$911,014K Total currentliabilities$23,517K Deferred revenue, net ofcurrent portion$12,041K Operating leaseliabilities, net of current...$3,055K Preferred stock-SeriesXRedeemable Convertible...$95,324K Common stock, 0.001 parvalue per share,...$57K Accumulated othercomprehensive gain$56K Accrued expenses$16,481K Deferred revenue,current$4,495K Operating leaseliabilities, current$1,404K Accounts payable$1,137K

Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics, Inc. (ATXS)